Enterovirus D: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 1: | Line 1: | ||
Enterovirus | {{short description|Overview of Enterovirus D68}} | ||
{{Use dmy dates|date=October 2023}} | |||
Enterovirus | ==Overview== | ||
[[Enterovirus D68]] (EV-D68) is a member of the [[Picornaviridae]] family, which includes other notable viruses such as [[poliovirus]] and [[rhinovirus]]. EV-D68 is a non-enveloped, positive-sense [[single-stranded RNA virus]] that primarily affects the respiratory system. It was first identified in 1962 in California, United States. | |||
== Virology == | ==Virology== | ||
EV-D68 is classified within the species [[Enterovirus D]], which is part of the genus [[Enterovirus]]. The virus is characterized by its small, icosahedral structure and its ability to survive in acidic environments, a common trait among enteroviruses. The genome of EV-D68 is approximately 7,500 nucleotides in length and encodes a single polyprotein that is cleaved into structural and non-structural proteins. | |||
==Transmission== | |||
The primary mode of transmission for EV-D68 is through respiratory secretions, such as saliva, nasal mucus, or sputum. The virus can spread from person to person via close contact, coughing, or sneezing. It can also be transmitted by touching surfaces contaminated with the virus and then touching the face. | |||
=== | ==Clinical Manifestations== | ||
EV-D68 infections can range from mild respiratory illness to severe respiratory distress. Common symptoms include [[fever]], [[runny nose]], [[sneezing]], [[cough]], and [[muscle aches]]. In severe cases, particularly in children and individuals with asthma, EV-D68 can lead to [[wheezing]] and difficulty breathing. | |||
==Epidemiology== | |||
EV-D68 has been associated with outbreaks of respiratory illness worldwide. Notably, in 2014, a large outbreak occurred in the United States, leading to increased hospitalizations and cases of severe respiratory illness. The virus tends to circulate in late summer and early fall, similar to other enteroviruses. | |||
== | ==Prevention and Control== | ||
Currently, there is no specific antiviral treatment or vaccine for EV-D68. Preventive measures include practicing good hand hygiene, avoiding close contact with infected individuals, and cleaning frequently touched surfaces. Public health measures during outbreaks focus on surveillance and supportive care for affected individuals. | |||
==Research== | |||
Ongoing research aims to better understand the pathogenesis of EV-D68, its epidemiology, and potential therapeutic interventions. Studies are also exploring the genetic diversity of the virus and its evolution over time. | |||
==Images== | |||
[[File:Ev-d68-photo-1.jpg|thumb|right|Electron micrograph of Enterovirus D68]] | |||
== | |||
==Related pages== | |||
* [[Enterovirus]] | * [[Enterovirus]] | ||
* [[Picornaviridae]] | * [[Picornaviridae]] | ||
* [[Respiratory illness]] | * [[Respiratory illness]] | ||
* [[Viral infection]] | |||
[[Category:Enteroviruses]] | [[Category:Enteroviruses]] | ||
[[Category:Viral respiratory tract infections]] | [[Category:Viral respiratory tract infections]] | ||
Latest revision as of 11:19, 15 February 2025
Overview of Enterovirus D68
Overview[edit]
Enterovirus D68 (EV-D68) is a member of the Picornaviridae family, which includes other notable viruses such as poliovirus and rhinovirus. EV-D68 is a non-enveloped, positive-sense single-stranded RNA virus that primarily affects the respiratory system. It was first identified in 1962 in California, United States.
Virology[edit]
EV-D68 is classified within the species Enterovirus D, which is part of the genus Enterovirus. The virus is characterized by its small, icosahedral structure and its ability to survive in acidic environments, a common trait among enteroviruses. The genome of EV-D68 is approximately 7,500 nucleotides in length and encodes a single polyprotein that is cleaved into structural and non-structural proteins.
Transmission[edit]
The primary mode of transmission for EV-D68 is through respiratory secretions, such as saliva, nasal mucus, or sputum. The virus can spread from person to person via close contact, coughing, or sneezing. It can also be transmitted by touching surfaces contaminated with the virus and then touching the face.
Clinical Manifestations[edit]
EV-D68 infections can range from mild respiratory illness to severe respiratory distress. Common symptoms include fever, runny nose, sneezing, cough, and muscle aches. In severe cases, particularly in children and individuals with asthma, EV-D68 can lead to wheezing and difficulty breathing.
Epidemiology[edit]
EV-D68 has been associated with outbreaks of respiratory illness worldwide. Notably, in 2014, a large outbreak occurred in the United States, leading to increased hospitalizations and cases of severe respiratory illness. The virus tends to circulate in late summer and early fall, similar to other enteroviruses.
Prevention and Control[edit]
Currently, there is no specific antiviral treatment or vaccine for EV-D68. Preventive measures include practicing good hand hygiene, avoiding close contact with infected individuals, and cleaning frequently touched surfaces. Public health measures during outbreaks focus on surveillance and supportive care for affected individuals.
Research[edit]
Ongoing research aims to better understand the pathogenesis of EV-D68, its epidemiology, and potential therapeutic interventions. Studies are also exploring the genetic diversity of the virus and its evolution over time.
Images[edit]
